In the US and globally, there have been two secular events exogenous to the HCV epidemic that has impacted HCV negatively. The first is well documented with the accompanying rise in the Opioid epidemic resulting in the uptick in HCV infections particularly among the population younger than the baby boomer generation. The second is the advent of COVID-19 that caused disruptions in testing, linkage and treatment of people living with Hepatitis C. We showcase the impact COVID 19 had on our testing program in Alabama.